Scottish scientists have been awarded funding to work on a “ground-breaking” anti-cancer drug that could be “up to 500 times more effective” than current treatments. Research at the University of Edinburgh is still in its early stages, but it aims to target blood and solid cancers. It was one of 18 innovation projects across ten Scottish universities to receive a portion of the £2.95m investment. “The successful projects that we are supporting are quite simply inspiring. “The transition from ground-breaking discovery to real-world application is one of the most critical stages in research,” he said.